PSMA-expressing, fluciclovine-negative vertebral hemangioma

This case highlights the role of fluciclovine PET-CT in distinguishing benign vertebral hemangiomas from prostate cancer metastases, improving diagnostic accuracy specifically in positive cases of PSMA PET-CT.

Authors

Amin Haghighat Jahromi (ORCID: https://orcid.org/0000-0002-8263-903X)
Azadeh Eslambolchi

Institutions

Mallinckrodt (United States) (US)

Publication Details

Journal: EJNMMI Research
Published: 2025-05-09
DOI: https://doi.org/10.1186/s13550-025-01248-0
Citations: 1
Primary Topic: Glioma Diagnosis and Treatment
Type: article
Field-Weighted Citation Impact: 1.63

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

PSMA-expressing, fluciclovine-negative vertebral hemangioma

Amin Haghighat Jahromi, Azadeh Eslambolchi

May 9, 2025

1 citations

EJNMMI Research

Glioma Diagnosis and Treatment

1.63

article

PSMA-expressing, fluciclovine-negative vertebral hemangioma

Amin Haghighat Jahromi, Azadeh Eslambolchi

May 9, 2025article en

1 citations

Abstract

EJNMMI ResearchVol. 15(1)

Mallinckrodt (United States) (US)

Openalex Percentile: Top 18%

Glioma Diagnosis and Treatment

1.63

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

PSMA-expressing, fluciclovine-negative vertebral hemangioma — Amin Haghighat Jahromi, Azadeh Eslambolchi · EJNMMI Research (2025) | TGRS Research Map | TGRS